Human retinal explant culture for ex vivo validation of AAV gene therapy

Methods in Molecular Biology

Volumn 1715, Issue , 2018, Pages 289-303

  Orlans, Harry O ^a,b,c   Edwards, Thomas L ^a,b   De Silva, Samantha R ^a,b   Patrício, Maria I ^a   MacLaren, Robert E ^a,b,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b OXFORD EYE HOSPITAL   (United Kingdom)

^c MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

AAV; Culture; Gene therapy; Human retina

Indexed keywords

ADENO ASSOCIATED VIRUS VECTOR;

EX VIVO STUDY; EXPLANT; GENE EXPRESSION; GENE THERAPY; HUMAN; HUMAN TISSUE; RETINA TISSUE; SURGICAL TECHNIQUE; TISSUE CULTURE; VIRAL GENE DELIVERY SYSTEM; DEPENDOPARVOVIRUS; GENE TRANSFER; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; METABOLISM; ORGAN CULTURE TECHNIQUE; PHYSIOLOGY; PROCEDURES; RETINA; TRANSGENE;

DEPENDOVIRUS; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GENETIC VECTORS; HUMANS; ORGAN CULTURE TECHNIQUES; RETINA; TRANSDUCTION, GENETIC; TRANSGENES;

EID: 85036617688     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-7522-8_21     Document Type: Chapter

References (15)

1. Mingozzi F, High KA (2011) Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nat Rev Genet 12:341–355
2. Smith J, Ward D, Michaelides M et al (2015) New and emerging technologies for the treatment of inherited retinal diseases: a horizon scanning review. Eye 29:1131–1140
3. Bainbridge JWB, Smith AJ, Barker SS et al (2008) Effect of gene therapy on visual function in Leber’s congenital amaurosis. N Engl J Med 358:2231–2239
4. MacLaren RE, Groppe M, Barnard AR et al (2014) Retinal gene therapy in patients with choroideremia: Initial findings from a phase 1/2 clinical trial. Lancet 383:1129–1137
5. Ghazi NG, Abboud EB, Nowilaty SR et al (2016) Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial. Hum Genet 135:327–343
6. Mcclements ME, Maclaren RE (2013) Gene therapy for retinal disease. Transl Res 161:241–254
7. Loeb JE, Cordier WS, Harris ME et al (1999) Enhanced expression of transgenes from adeno-associated virus vectors with the woodchuck hepatitis virus posttranscriptional regulatory element: implications for gene therapy. Hum Gene Ther 10:2295–2305
8. Patricio MI, Barnard AR, Orlans HO et al (2017) Inclusion of the woodchuck hepatitis virus posttranscriptional regulatory element enhances AAV2 mediated transduction of mouse and human retina. Mol Ther Nucleic Acids (in press)
9. McCarty DM (2008) Self-complementary AAV Vectors; advances and applications. Mol Ther 16:1648–1656
10. Petersen-Jones SM, Bartoe JT, Fischer AJ et al (2009) AAV retinal transduction in a large animal model species: comparison of a self-complementary AAV2/5 with a single-stranded AAV2/5 vector. Mol Vis 15:1835–1842
11. Asokan A, Schaffer DV, Samulski RJ (2012) The AAV vector toolkit: poised at the clinical crossroads. Mol Ther 20:699–708
12. Tolmachova T, Tolmachov OE, Barnard AR et al (2013) Functional expression of Rab escort protein 1 following AAV2-mediated gene delivery in the retina of choroideremia mice and human cells ex vivo. J Mol Med 91:825–837
13. De Silva SR, Issa PC, Singh MS et al (2016) Single residue AAV capsid mutation improves transduction of photoreceptors in the Abca4−/− mouse and bipolar cells in the rd1 mouse and human retina ex vivo. Gene Ther 23:767–774
14. Johnson TV, Martin KR (2008) Development and characterization of an adult retinal explant organotypic tissue culture system as an in vitro intraocular stem cell transplantation model. Invest Ophthalmol Vis Sci 49:3503–3512
15. Issa PC, Singh MS, Lipinski DM et al (2012) Optimization of in vivo confocal autofluorescence imaging of the ocular fundus in mice and its application to models of human retinal degeneration. Invest Ophthalmol Vis Sci 53:1066–1075